Bulletin
Investor Alert

New York Markets Close in:

Humana Inc.

NYS: HUM

GO
/marketstate/country/us

Market open

 --Real time quotes

Apr 8, 2020, 9:43 a.m.

HUM
/zigman2/quotes/203095337/lastsale

$

325.34

Change

+5.28 +1.65%

Volume

Volume 12,939

Real time quotes

/zigman2/quotes/203095337/lastsale

Previous close

$ 320.05

$ 325.34

Change

+5.28 +1.65%

Day low

Day high

$319.33

$326.14

Open

52 week low

52 week high

$208.25

$385.00

Open

Company Description

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services.. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans su...

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services.. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance benefits. The Healthcare Services segment offer services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics services to other Humana businesses, as well as external health plan members, external health plans, and other employers. The company was founded by David A. Jones, Sr. and Wendell Cherry in 1961 and is headquartered in Louisville, KY.

Valuation

P/E Current

16.30

P/E Ratio (with extraordinary items)

16.13

P/E Ratio (without extraordinary items)

18.24

Price to Sales Ratio

0.76

Price to Book Ratio

4.02

Price to Cash Flow Ratio

9.35

Enterprise Value to EBITDA

11.76

Enterprise Value to Sales

0.68

Total Debt to Enterprise Value

0.11

Efficiency

Revenue/Employee

1,410,609.00

Income Per Employee

58,848.00

Total Asset Turnover

2.36

Liquidity

Current Ratio

1.60

Profitability

Operating Margin

4.92

Pretax Margin

5.33

Net Margin

4.17

Return on Assets

9.85

Return on Equity

24.39

Return on Total Capital

18.57

Return on Invested Capital

16.99

Capital Structure

Total Debt to Total Equity

50.79

Total Debt to Total Capital

33.68

Total Debt to Total Assets

20.86

Long-Term Debt to Equity

44.02

Long-Term Debt to Total Capital

29.19

Officers and Executives

Name Age Officer Since Title
Mr. Bruce Dale Broussard 56 2011 President
Mr. Brian A. Kane 46 2014 Chief Financial Officer & Senior Vice President
Dr. Brian P. LeClaire 58 1999 Senior VP, Chief Service & Information Officer
Mr. Sam Deshpande - 2017 SVP, Chief Risk & Technology Officer
Dr. William Shrank - 2019 Chief Medical Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/20/2020 David A. Jones
Director
5,800   Disposition at $256.19 per share. 1,485,902
03/13/2020 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
1,500   Acquisition at $289.4 per share. 434,100
03/09/2020 Timothy S. Huval
Chief Administrative Officer
980   Disposition at $343.06 per share. 336,198
03/09/2020 Timothy S. Huval
Chief Administrative Officer
12,457   Disposition at $342.89 per share. 4,271,380
03/09/2020 Timothy S. Huval
Chief Administrative Officer
278   Derivative/Non-derivative trans. at $359.85 per share. 100,038
03/09/2020 Timothy S. Huval
Chief Administrative Officer
7,290   Derivative/Non-derivative trans. at $217.42 per share. 1,584,991
03/09/2020 Timothy S. Huval
Chief Administrative Officer
5,167   Derivative/Non-derivative trans. at $217.42 per share. 1,123,409
03/09/2020 Timothy S. Huval
Chief Administrative Officer
459   Derivative/Non-derivative trans. at $217.42 per share. 99,795
03/08/2020 Brian A. Kane
Chief Financial Officer
1,061   Derivative/Non-derivative trans. at $359.85 per share. 381,800
03/08/2020 Christopher H. Hunter
Seg Pres. Gr. & Military Bus.
609   Derivative/Non-derivative trans. at $359.85 per share. 219,148
03/08/2020 Timothy Alan Wheatley
Segment President, Retail
766   Derivative/Non-derivative trans. at $359.85 per share. 275,645
03/08/2020 Timothy S. Huval
Chief Administrative Officer
802   Derivative/Non-derivative trans. at $359.85 per share. 288,599
03/08/2020 William Fleming
Seg Pres, Clin & Phm Solutions
718   Derivative/Non-derivative trans. at $359.85 per share. 258,372
03/08/2020 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
352   Derivative/Non-derivative trans. at $359.85 per share. 126,667
03/08/2020 Susan Diamond
Segment President, Home Bus.
363   Derivative/Non-derivative trans. at $359.85 per share. 130,625
03/08/2020 Joseph C Ventura
Chief Legal Officer
218   Derivative/Non-derivative trans. at $359.85 per share. 78,447
03/08/2020 Brian A. Kane
Chief Financial Officer
2,299   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 Christopher H. Hunter
Seg Pres. Gr. & Military Bus.
1,494   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 Timothy Alan Wheatley
Segment President, Retail
1,724   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 Timothy S. Huval
Chief Administrative Officer
1,782   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 William Fleming
Seg Pres, Clin & Phm Solutions
1,724   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
1,115   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 Susan Diamond
Segment President, Home Bus.
1,149   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 Joseph C Ventura
Chief Legal Officer
689   Derivative/Non-derivative trans. at $0 per share. 0
02/28/2020 Susan Diamond
Segment President, Home Bus.
1,785   Acquisition at $319.68 per share. 570,628
02/21/2020 Brian A. Kane
Chief Financial Officer
5,063   Derivative/Non-derivative trans. at $367.39 per share. 1,860,095
02/21/2020 Brian A. Kane
Chief Financial Officer
9,149   Derivative/Non-derivative trans. at $370.67 per share. 3,391,259
02/21/2020 Brian A. Kane
Chief Financial Officer
4,478   Derivative/Non-derivative trans. at $367.39 per share. 1,645,172
02/21/2020 Brian A. Kane
Chief Financial Officer
8,526   Derivative/Non-derivative trans. at $370.67 per share. 3,160,332
02/21/2020 Brian A. Kane
Chief Financial Officer
270   Derivative/Non-derivative trans. at $370.67 per share. 100,080
02/21/2020 Brian A. Kane
Chief Financial Officer
809   Derivative/Non-derivative trans. at $370.67 per share. 299,872
02/21/2020 Brian A. Kane
Chief Financial Officer
20,209   Derivative/Non-derivative trans. at $167.8 per share. 3,391,070
02/21/2020 Brian A. Kane
Chief Financial Officer
19,193   Derivative/Non-derivative trans. at $164.64 per share. 3,159,935
02/21/2020 Brian A. Kane
Chief Financial Officer
595   Derivative/Non-derivative trans. at $167.8 per share. 99,841
02/21/2020 Brian A. Kane
Chief Financial Officer
1,821   Derivative/Non-derivative trans. at $164.64 per share. 299,809
01/02/2020 David A. Jones
Director
453   Award at $0 per share. 0
01/02/2020 Webster Roy Dunbar
Director
453   Award at $0 per share. 0
01/02/2020 Marissa T. Peterson
Director
453   Award at $0 per share. 0
01/02/2020 Frank J. Bisignano
Director
453   Award at $0 per share. 0
01/02/2020 James J. O'Brien
Director
453   Award at $0 per share. 0
12/24/2019 Heather Cox
Chief Dig Health & Analyt Off.
380   Acquisition at $368.63 per share. 140,079
12/24/2019 Heather Cox
Chief Dig Health & Analyt Off.
370   Acquisition at $368.16 per share. 136,219
12/20/2019 Timothy S. Huval
Chief Administrative Officer
1,050   Gift at $0 per share. 0
12/18/2019 Elizabeth D. Bierbower
Strategic Advisor
5,347   Disposition at $370 per share. 1,978,390
12/18/2019 Elizabeth D. Bierbower
Strategic Advisor
5,347   Derivative/Non-derivative trans. at $217.42 per share. 1,162,544
/news/latest/company/us/hum

MarketWatch News on HUM

  1. The Pandemic Highlights the Top U.S. Pot Producers

    8:29 p.m. April 3, 2020

    - Bill Alpert

  2. How Insurers Will Weather the Coronavirus Storm

    11:51 a.m. March 17, 2020

    - Josh Nathan-Kazis

  3. Stocks Finish the Week Higher. The Pain Isn’t Over.

    3:31 p.m. March 7, 2020

    - Ben Levisohn

  4. Alignment Healthcare Raises $135 Million

    3:21 p.m. March 4, 2020

    - Luisa Beltran

  5. Loading more headlines...
/news/nonmarketwatch/company/us/hum

Other News on HUM

  1. UnitedHealth Will Speed Payments to Doctors, Hospitals Amid Pandemic

    5:30 p.m. April 7, 2020

    - Anna Wilde Mathews

  2. Anthem to Remove Costs Related to Coronavirus Treatment

    9:56 a.m. April 2, 2020

    - Zacks.com

  3. COVID-19 actions - healthcare

    7:44 a.m. April 2, 2020

    - Seeking Alpha

  4. CVS Stock Is a Winner Beyond the Pandemic

    12:20 p.m. March 31, 2020

    - InvestorPlace.com

  5. Humana to Waive Expenses Related to Coronavirus Treatment

    12:17 p.m. March 31, 2020

    - Zacks.com

  6. Cigna (CI) Ramps up Efforts to Contain Coronavirus Spread

    10:23 a.m. March 31, 2020

    - Zacks.com

  7. SEM vs. HUM: Which Stock Should Value Investors Buy Now?

    11:40 a.m. March 30, 2020

    - Zacks.com

  8. UnitedHealth Offers Relief to Clients in Houston Amid Crisis

    10:38 a.m. March 30, 2020

    - Zacks.com

  9. Wall Street Breakfast: Investors Prepare For More Market Swings

    7:01 a.m. March 30, 2020

    - Seeking Alpha

  10. More insurers waive COVID-19 charges

    3:08 a.m. March 30, 2020

    - Seeking Alpha

  11. Teladoc (TDOC) Up 90% Year to Date: Will the Rally Continue?

    12:43 p.m. March 27, 2020

    - Zacks.com

  12. 21 Upcoming Dividend Increases

    10:04 a.m. March 26, 2020

    - Seeking Alpha

  13. Covid-19-related activity - healthcare

    7:37 a.m. March 25, 2020

    - Seeking Alpha

  14. A Director at Humana (HUM) is Selling Shares

    9:59 p.m. March 24, 2020

    - SmarterAnalyst

  15. Loading more headlines...

At a Glance

Humana, Inc.

500 West Main Street

Louisville, Kentucky 40202

Phone

1 5025801000

Industry

Life Insurance

Sector

Financial Services

Fiscal Year-end

12/2020

Revenue

$64.89B

Net Income

$2.71B

2019 Sales Growth

14.0%

Employees

46,000

/news/pressrelease/company/us/hum

Press Releases on HUM

  1. Humana $HUM Trading Report

    8:41 p.m. April 7, 2020

    - Stock Traders Daily

  2. Humana Inc. to Release First Quarter 2020 Results on April 29, 2020

    5:00 p.m. April 1, 2020

    - BusinessWire - BZX

  3. Humana to Waive Medical Costs Related to Coronavirus Treatment

    7:00 a.m. March 30, 2020

    - BusinessWire - BZX

  4. Humana Completes Aggregate $1.1 Billion Debt Offering

    4:45 p.m. March 26, 2020

    - BusinessWire - BZX

  5. Humana Works to Increase Capacity for Coronavirus Treatment

    10:15 a.m. March 26, 2020

    - BusinessWire - BZX

  6. Humana Prices $1.1 Billion Debt Offering

    8:43 p.m. March 23, 2020

    - BusinessWire - BZX

  7. Humana $HUM Trading Report

    9:42 a.m. March 10, 2020

    - Stock Traders Daily

  8. Humana Takes Steps to Care for Members in Response to Coronavirus

    4:47 p.m. March 9, 2020

    - BusinessWire - BZX

  9. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.